Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Clinical Insights

Clinical Insights
Pancreatic Irreversible Electroporation: An Alternative to Pancreatic Metastasectomy?
04/01/2015
Abstract: In the presence of metastatic disease, the 5-year overall survival drops from 74% to approximately 8% in patients with renal cell carcinoma. Solitary metastases to the pancreas are uncommon, as disease is more often found in the...
Abstract: In the presence of metastatic disease, the 5-year overall survival drops from 74% to approximately 8% in patients with renal cell carcinoma. Solitary metastases to the pancreas are uncommon, as disease is more often found in the...
Abstract: In the presence of...
04/01/2015
IO Learning
Clinical Insights
Prostatic Artery Embolization for Intractable Hematuria in Prostate Cancer
03/25/2015
Abstract: Hematuria due to prostatic hemorrhage secondary to malignancy can be a life threatening condition. Therapeutic options include hormonal therapy, radiation therapy, and surgery. Transarterial embolization is emerging as a minimally...
Abstract: Hematuria due to prostatic hemorrhage secondary to malignancy can be a life threatening condition. Therapeutic options include hormonal therapy, radiation therapy, and surgery. Transarterial embolization is emerging as a minimally...
Abstract: Hematuria due to...
03/25/2015
IO Learning
Clinical Insights
Cancer Biology for Interventional Oncology Clinicians: An Interview With Jean-Francois Geschwind, MD
03/19/2015
At the the 2015 Society of Interventional Radiology Annual Scientific Meeting, Jean-Francois Geschwind, MD, presented information for interventional oncology clinicians about cancer biology. Interventional Oncology 360 asked Dr. Geschwind to...
At the the 2015 Society of Interventional Radiology Annual Scientific Meeting, Jean-Francois Geschwind, MD, presented information for interventional oncology clinicians about cancer biology. Interventional Oncology 360 asked Dr. Geschwind to...
At the the 2015 Society of...
03/19/2015
IO Learning
Clinical Insights
Ablation for Lung Tumors: An Interview With Constantinos T. Sofocleous, MD, PhD
03/05/2015
Editor's note: View video of this interview here.At the 2015 Symposium on Clinical Interventional Oncology, part of the International Symposium on Endovascular Therapy, Constantinos T. Sofocleous, MD, PhD, of the Memorial Sloan Kettering...
Editor's note: View video of this interview here.At the 2015 Symposium on Clinical Interventional Oncology, part of the International Symposium on Endovascular Therapy, Constantinos T. Sofocleous, MD, PhD, of the Memorial Sloan Kettering...
Editor's note: View video of...
03/05/2015
IO Learning
Clinical Insights
Radiofrequency Ablation of Vertebral Alveolar Soft Part Sarcoma Metastasis With the STAR Tumor Ablation System After Attempted Palliation With External Beam Radiation
02/18/2015
Abstract: Alveolar soft part sarcoma is a rare malignancy that is known to be resistant to radiation therapy and chemotherapy. The traditional methods are (1) vertebral debulking with or without stabilization and (2) irradiation. The STAR...
Abstract: Alveolar soft part sarcoma is a rare malignancy that is known to be resistant to radiation therapy and chemotherapy. The traditional methods are (1) vertebral debulking with or without stabilization and (2) irradiation. The STAR...
Abstract: Alveolar soft part...
02/18/2015
IO Learning
Clinical Insights
Fellowships in Interventional Oncology Help Meet the Need for Credentialed Practitioners
01/27/2015
An uptick in the use of interventional oncology is spurring creation of programs and opportunities for physicians and medical students who want to explore these new, minimally invasive therapies in a structured educational setting....
An uptick in the use of interventional oncology is spurring creation of programs and opportunities for physicians and medical students who want to explore these new, minimally invasive therapies in a structured educational setting....
An uptick in the use of...
01/27/2015
IO Learning
Clinical Insights
Adrenal Tumors: Anatomy, Physiology, Diagnosis, and Treatment
01/26/2015
Abstract: Adrenal tumors are relatively common as seen on autopsy studies and computed tomography scans. Currently surgery is the treatment of choice for functioning adrenal adenomas and malignancies. Laparoscopy is the preferred surgical...
Abstract: Adrenal tumors are relatively common as seen on autopsy studies and computed tomography scans. Currently surgery is the treatment of choice for functioning adrenal adenomas and malignancies. Laparoscopy is the preferred surgical...
Abstract: Adrenal tumors are...
01/26/2015
IO Learning
Clinical Insights
Interventional Oncology at the National Cancer Institute in Brazil: An Interview With Jose Hugo Mendes Luz, MD
12/30/2014
At the 2014 Synergy interventional oncology meeting in Miami, Florida, Interventional Oncology 360 spoke with editorial board member Jose Hugo Mendez Luz, MD, from the National Cancer Institute (INCA) in Rio de Janiero, Brazil, about the...
At the 2014 Synergy interventional oncology meeting in Miami, Florida, Interventional Oncology 360 spoke with editorial board member Jose Hugo Mendez Luz, MD, from the National Cancer Institute (INCA) in Rio de Janiero, Brazil, about the...
At the 2014 Synergy...
12/30/2014
IO Learning
Clinical Insights
Identification and Management of Patients at Risk for Contrast-Induced Nephropathy: A Practical Approach
12/19/2014
Contrast-induced nephropathy (CIN), or acute kidney injury from an iodinated contrast agent, is an important complication in the use of iodinated contrast media that accounts for a significant number of cases of hospital-acquired acute kidney...
Contrast-induced nephropathy (CIN), or acute kidney injury from an iodinated contrast agent, is an important complication in the use of iodinated contrast media that accounts for a significant number of cases of hospital-acquired acute kidney...
Contrast-induced nephropathy...
12/19/2014
IO Learning
Clinical Insights
The Role of Interventional Oncology in Patients With Gynecologic Malignancies
12/17/2014
Abstract: The primary treatment of gynecologic malignancies has typically involved surgical resection and chemotherapy with the role of interventional radiologists primarily relegated to obtaining a tissue diagnosis. That paradigm...
Abstract: The primary treatment of gynecologic malignancies has typically involved surgical resection and chemotherapy with the role of interventional radiologists primarily relegated to obtaining a tissue diagnosis. That paradigm...
Abstract: The primary treatment...
12/17/2014
IO Learning

Advertisement

Subscribe

IO Learning Newsletter

News

News
Novel Endovascular Robotic Surgical System Reaches Midpoint of Pivotal Clinical Trial
09/20/2024
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY®...
09/20/2024
IO Learning
News
Histotripsy Demonstrates Technical Success, Safety for Primary and Metastatic Liver Tumors
09/04/2024
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the...
09/04/2024
IO Learning
News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement